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Summary: A new immunochemical method for the measurement of lactate dehydrogenase isoenzyme l (LDH-1)
was used on 113 consecutively admitted patients with suspected myocardial infarction. Using WHO's criteria and
our routine program 49 were classified äs having myocardial infarction and 64 äs having no myocardial infarction.
LDH-1 was better than total lactate dehydrogenase in discriminating between patients with and without myocardial
infarction (p < 0.02), and the efficiency (the number of correct classifications divided by the total number of analyses)
on day 2-3 equalled that from the literature for CK-MB on day 1. Total lactate dehydrogenase and LDH-1 are supple-
mental to creatine kinase (CK) and CK-MB, while aspartate aminotransferase may be omitted in the diagnosis of
myocardial infarction. Determination of the ratio of LDH-1 to total lactate dehydrogenase qffered no advantage.
Lactatdehydrogenäse-Isoenzym l in der Diagnostik des Herzinfarkts
Zusammenfassung: Zur Bestimmung von Lactatdehydrogenäse-Isoenzym l (LDH-1) bei 113 mit Verdacht auf Myo-
kardinfarkt eingewiesenen Patienten wurde eine neue immunchemische Methode angewandt. Aufgrund der WHO-
Kriterien und unseres Routineprogramms wurden 49 Patienten als mit Herzinfarkt und 64 als ohne Herzinfarkt klassi-
fiziert. Für die Diskriminierung Myokardinfarkt/kein Myokardinfarkt war LDH-1 besser (p < 0,02) als Gesamt-Lactat-
dehydrogenase geeignet und die Effizienz (korrekte Klassifikation/Gesamtzahl der Analysen) an Tag 2—3 entsprach der
aus der Literatur für CK-MB an Tag l. Gesamt-Lactatdehydrogenase und LDH-1 ergänzen Kreatinkinase (CK) und
CK-MB, während Aspartataminqtransferase für die Diagnostik des Myokardinfarkts entfallen kann. Die Bestimmung
des Verhältnisses LDH-1/Gesamt-Lactat dehydrogenase bringt keinen Vorteil.
Introduction ,._ . , A A fr. _ . . , „differences m Substrate affimties, temperature and pH
Lactate dehydrogenase (LDH) is a tetrameric molecule sensitivity, inhibitors and chromatography have been
consisting of four subunits of either H (heart) or M used. Separation of the isoenzymes by these other
(muscle) type. Various combinations of H and M yield methods is incomplete, and electrophoresis followed
five different teträmers. Lactate dehydrogenase isq- by enzyme staining is time-consuming and tedious. The
enzyme l (LDH-1) migrates fastest towards the anöde purpose of the present study is to examine a commerci-
during enzyme-^lectrophoresis, and it consits of four H ally available method for the measurement of LDH-1
subunits. After heart muscle damage serum LDH-1 par- after immunochemical removal of the other isoenzymes,
ticularly increäses, and it is used to diagnose acute myo- and to apply the analysis to the diagnosis of myocardial
cardial infarction. In addition to enzyme-electrophoresis, infarction.
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Patients
We investigated all patients with suspected myocardial infarction
admitted to the department of cardiology during December
1980. The department receives all patients with suspected myo-
cardial infarction from a district with 181439 inhabitants. 113
patients, 31 women and 82 men, were admitted with this dia-
gnosis. The mean ages of the women and the inen were 70 and
60 years, respectively.
The diagnosis of definite myocardial infarction was based on
WHO's criteria (1), which demand
DatypicalECGor
2) an equivocal ECG with definite enzymes or
3) a typical history with definite enzymes or
4) a positive post-mortem.
Patients not fulfilling WHO's demands were classified äs no
myocardial infarction. Of the 113 patients, 49 had myo-
cardial infarction and 64 had no myocardial infarction. There
were no significant age or sex differences between the two
groups, and the prevalence of myocardial infarction is the
usual for a cardiology department.
40 of the 49 patients with myocardial infarction were admitted
on the same day äs the onset of ehest pain, four between 24
and 48h, three between 48 and 72 h, and two more than three
day s after the pain started.
The 64 patients without myocardial infarction shared the
following diagnoses: 33 angina pectoris, 11 arrhythmias,
9 heart failure, 4 bronchitis, 3 pneumonia, 3 peptic ulcer,
2 acute pericarditis, 2 pneumothorax, 2 alcohol abuse,
l pulmonary embolism, l lung neoplasm, 15 musculoskeletal
pains, 2 anxiety neurosis, and 3 miscellaneous.
Methods
The patients went through the routine examination program
of the department. The blood samples for total lactate
dehydrogenase and aspartate aminotransferase were drawn
on admission and in the morning of thel., 2., 3., 5., and
7. day s. If the admission coincided with the morning sampling
on day l, only one sample was taken that day. *
Total lactate dehydrogenase and LDH-1 were measured simul-
taneously, and the result of the LDH-1 determination was not
known by the cardiologist. The diagnosis was not known by the
laboratory. All enzyme activities were measured with a LKB
2086 kinetic analyzer (3).
We measured LDH-1 äs the residual enzyme activity after
immunochemical removal of the other isoenzyme fractions.
100 serum was used. Göat antibody to M subunits was
added, followed by donkey anti-goat immunoglobulin bound
to inert particles (2). (isomune-LD, Röche Diagnostics, Nutley,
NJ 07110). After centrifuging, only LDH-1 (cpnsisting of four
H subunits) remained in the supernatant. Samples with total
lactate dehydrogenase above 1000 U/l were dilüted before the
addition of antibody. Enzyme-electrpphoresis in agarose gel
with subsequent staining and visual estimate (4) was performed
äs an accuracy control.
Paiied t-test was used to evaluate differences between paked
observatiöns.
Results
Figure l shpws the primäry LDH?1 data. Discriminätoiy
or cut-off limits were chosen to maxünize the effieieiicy
on each day following the myocardial infarction. By
efficiency is meant the number of cörrect divided by
the total number of classificätions. We regard wrong
positive and wrong negative diagnoses äs equally bäd,
in agreement with common practice (5). The chosen
limits are shown in table l.
Tables 2—4 show the efficiency, specificity, and sensi-
tivity, respectively, for total lactate dehydtögenase
and LDH-1 on each day, (The specificity is the ratip
of negatives to total samples from patients without
myocardial infarction, and the sensitivity is the rätiö
of positives to total samples from patients with myo-
cardial infärctiori (5,6)). The efficiency is significantly








Day 1 Oay2 Day 3 OayS Oay 7
Fig. 1. Distribution of the LDH-1 results from patients with (·) and without myocardial infarction (ö) (log scale) on each day
following the acute attack, with the chosen discrimination values. > ;
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Tab. 1. Discriminatory or cut-off limits for LDH-1 and total
lactate dehydrogenase (LDH) (U/1, 37 °C) on each
day after the onset of Symptoms. The limits are chosen
to give the maximum number of correct classifications
on each day. The cut-off limits for total lactate dehydro-
genase differ from the usual upper limit of normal
(450 U/l, 37 °C), because some patients without myo^
cardial infarction had slightly elevated levels while
patients with myocardial infarction had transient high
values.













Tab. 2. The efficiency of LDH-1 and total lactate dehydro-
genase (LDH) (the incidence of true positives and true
























Tab. 3. The specificity of LDH-1 and total lactate dehydro-
genase (LDH) (the incidence of results below the cut-
off limit among patients without myocardial infarc-
tion). The number of analyses on day five and seven
are small because rtiany of the patients were discharged
























Tab. 4. The sexisitivity of LDH-1 and total lactate dehydro-
genase (LDH) (the incidence of results above the cut-























ratio of LDH-1 to total lactate dehydrogenase had
lower efficiencies than total lactate dehydrogenase,
even when the cut-off limits were chosen for maximum
efficiency.
The imprecision (SD) of the LDH-1 measurement was
4.3 U/l in the ränge 100-200 U/l (CV, 3%) and 9.8 U/l
in the ränge 200-1000 U/l (CV, l .5%), both calculated
from 40 duplicate measurements. Day-to-day impre-
cision was 10 U/l (CV, 2%), äs calculated from 20 daily
measurements on a control serum ("K 79", from the
Danish Society for Clinical Chemistry).
The accuracy was visually evaluated by enzyme-electro-
phoresis. The capacity of the antibody to inhibit the
other isoenzyme fractions was determined by diluting
serum from a patient with myocardial infarction and
heart failure with liver stasis. Figure 2 shows serum
with and without added antibody after dilution to a
total lactate dehydrogenase of 2600 U/l, which is the
approximate capacity of the antibody when the enzyme
is of mainly hepatic origin. Our practice of diluting
serum with total lactate dehydrogenase above 1000 U/l
thus assures the%complete removal of all enzyme activity
other than LDH-1.
Start
Fig. 2. Enzyme-electrophoresis showing lactate dehydrogenase
(LDH) isoenzymes before and after the immunochemical
LDH-1 procedure with antibody against M subunits. The
patient had myocardial infarction and heart failure with
liver stasis, and serum was düuted to a total lactate
dehydrögefiase of 2600 U/l (37 °C) to determine the
capacity of the antibody. LPH-1 lies to the right, and it is
unaltered because it cpnsists of four H subunits. LDH-2 is
barely visible, and the remaining three isoenzyme bands
have been completely removed.
considering all days (p < 0.02). Five patients with süb-
endocardial infarctions had total lactate dehydrogenase
below the cut-off limit on day 2 or 3, büt elevated
LDH-1. Three patients with heart failure without myo-
cardial infarction had elevated total lactate dehydro-
genase, but LDH-1 below the cut-off limit. One
patient with ventricular fibrillation without myocardial
infarction underwent direct current cardioversion and
had elevated total lactate dehydrogenase and LDH-1.
The usual upper limit for total lactate dehydrogenase
of 450 U/l (37 bC) gives a lower efficiency than the
chosen cut-off limits (0.77 vs. 0.86, respectively,
p < 0.02). Both aspartate aminotransferase and the
Discussion
The diagnosis of myocardial infarction is based on
patient history, ECG and routine laboratory data.
WHO's criteria give accurate and congruent clinical dia-
gnoses (7), and we do not think that the criteria should
be changed or the enzyme data be given more weight.
The future discrimination between patients with and
without myocardial infarction may however be
improved with better use and choice of enzyme investi-
gations. With this in mind we examined the value of
LDH-1 in a prospective study and compared it to the
value of total lactate dehydrogenase, aspartate amino-
transferase, and the ratio of LDH-1 to total lactate
dehydrogenase.
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We do not yet routinely measure creatine kinase iso-
enzyme (CK-MB), but when we do, a supplementary
lest will be needed for the patients who are admitted
more thaii 24 h after their myocardial infarction, when
CK-MB may have normalized (8-12). In the present
study, this was the case for 9 out of 49 patients. Total
lactate dehydrogenase and LDH-1 are an obvious choice,
and the study confirms that the efficiency of LDH-1
(2,13) 2-3 days after the myocardial infarction is äs
high äs others have found for CK-MB in the first 24 h
(14). The discriminatory or cut-off limits differ from
the usual upper normal limit, and they change with
time after the myocardial infarction. Theoretically
the time dependency is a draw back, but usually the
point of time of the myocardial infarction is known
with certainty. The patients with myocardial infarc-
tion had transient elevated levels, while some patients
without myocardial infarction had elevated but con-
stant enzyme levels. The efficiency depends on the
chosen upper limit, and an Optimum was reached by
considering the diagnostic Situation. Aspartate amino-
transferase and the ratio of LDH-1 to total lactate
dehydrogenase both had lower efficiencies than total
lactate dehydrogenase, which questions their use in
the diagnosis of myocardial infarction (8).
The patient with ventricular fibrillation who under-
went direct current cardioversion had both elevated
total lactate dehydrogenase and LDH-1, but not myo-
cardial infarction according to the WHO's criteria.
Others have found unchanged LDH-1 following direct
current cardioversion (15). It is possible that some
patients with coronary heart disease classified äs not
having myocardial infarction would have small in-
farctions detected by more sensitive means such äs
frequent CK-MB determinations or mycfcardial
scanning (16,17). The prognosis quoad vitam after
hospitalization with coronary heart disease does not
depend on the presence or abserice of myocardial
infarction (17), but LDH-1 mäy be useful in the
immediate prognosis and the estimation of infarction
size(18,19).
LDH-1 determination with the immunocheniical
technique is easy to perform, and the analysis has
satisfactory precision and accuracy. Disease in Organs
other than the heart will probably cause an increase
in LDH-1 since some other Organs also contain much
LDH-1 (e.g. erythrocytes, kidney and brain); but the
analysis is still relevant in the diagnosis of myocardial
infarction, because the prevalence of such diseases is
low amongst patients admitted with suspected myo-
cardial infarction (20, 21). The specificity of total
lactate dehydrogenase can be increased by using higher
cut-off limits, but LDH-1 still has a higher efficiency.
A future analysis program for patients with suspected
myocardial infarction should consist of CK-MB and
LDH-1, and the aspartate aminotransfefase analysis
may be omitted.
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